CO2024003968A2 - Composiciones de agentes de arni de proteína tau asociada a microtúbulos (mapt) y sus métodos de uso - Google Patents
Composiciones de agentes de arni de proteína tau asociada a microtúbulos (mapt) y sus métodos de usoInfo
- Publication number
- CO2024003968A2 CO2024003968A2 CONC2024/0003968A CO2024003968A CO2024003968A2 CO 2024003968 A2 CO2024003968 A2 CO 2024003968A2 CO 2024003968 A CO2024003968 A CO 2024003968A CO 2024003968 A2 CO2024003968 A2 CO 2024003968A2
- Authority
- CO
- Colombia
- Prior art keywords
- mapt
- compositions
- methods
- microtubule
- associated protein
- Prior art date
Links
- 102100040243 Microtubule-associated protein tau Human genes 0.000 title abstract 4
- 101710115937 Microtubule-associated protein tau Proteins 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 101150070547 MAPT gene Proteins 0.000 title abstract 2
- 108091030071 RNAI Proteins 0.000 title 1
- 230000009368 gene silencing by RNA Effects 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 201000011240 Frontotemporal dementia Diseases 0.000 abstract 1
- 208000034799 Tauopathies Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 201000002212 progressive supranuclear palsy Diseases 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229920002477 rna polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
- C12N2310/3125—Methylphosphonates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3515—Lipophilic moiety, e.g. cholesterol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
- C12N2310/3521—Methyl
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
- C12N2310/3527—Other alkyl chain
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/353—Nature of the modification linked to the nucleic acid via an atom other than carbon
- C12N2310/3533—Halogen
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La descripción se refiere a agentes de interferencia de ácido ribonucleico bicatenario (ARNbci) y composiciones que se dirigen a un gen de proteína tau asociada a microtúbulos (MAPT), así como métodos para inhibir la expresión de un gen MAPT y métodos para tratar sujetos que tienen una enfermedad o trastorno asociado a MAPT, p. ej., enfermedad de Alzheimer, demencia frontotemporal, parálisis supranuclear progresiva u otras tauopatías, utilizando dichos agentes de ARNbci y composiciones.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163248119P | 2021-09-24 | 2021-09-24 | |
US202263321573P | 2022-03-18 | 2022-03-18 | |
US202263403327P | 2022-09-02 | 2022-09-02 | |
PCT/US2022/076979 WO2023049871A2 (en) | 2021-09-24 | 2022-09-23 | Microtubule associated protein tau (mapt) irna agent compositions and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2024003968A2 true CO2024003968A2 (es) | 2024-04-18 |
Family
ID=85721285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2024/0003968A CO2024003968A2 (es) | 2021-09-24 | 2024-03-27 | Composiciones de agentes de arni de proteína tau asociada a microtúbulos (mapt) y sus métodos de uso |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP4405484A2 (es) |
KR (1) | KR20240067943A (es) |
AU (1) | AU2022348935A1 (es) |
CA (1) | CA3233101A1 (es) |
CO (1) | CO2024003968A2 (es) |
IL (1) | IL311564A (es) |
TW (1) | TW202328449A (es) |
WO (1) | WO2023049871A2 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023175091A2 (en) * | 2022-03-16 | 2023-09-21 | Janssen Pharmaceutica Nv | MAPT siRNA AND USES THEREOF |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6783961B1 (en) * | 1999-02-26 | 2004-08-31 | Genset S.A. | Expressed sequence tags and encoded human proteins |
DK1521831T3 (da) * | 2002-07-12 | 2008-06-30 | Axon Neuroscience | Transgent dyr der udtrykker trunkeret alzheimers tauprotein |
WO2005054464A1 (ja) * | 2003-12-03 | 2005-06-16 | Riken | 蛍光蛋白質 |
KR101876423B1 (ko) * | 2016-10-10 | 2018-07-09 | 한국과학기술연구원 | 치매 모델 형질전환 마우스 및 이를 이용한 스크리닝 방법 |
SG11202010910QA (en) * | 2018-05-07 | 2020-12-30 | Alnylam Pharmaceuticals Inc | Extrahepatic delivery |
US11827880B2 (en) * | 2019-12-02 | 2023-11-28 | Shape Therapeutics Inc. | Therapeutic editing |
-
2022
- 2022-09-23 WO PCT/US2022/076979 patent/WO2023049871A2/en active Application Filing
- 2022-09-23 AU AU2022348935A patent/AU2022348935A1/en active Pending
- 2022-09-23 TW TW111136260A patent/TW202328449A/zh unknown
- 2022-09-23 KR KR1020247013213A patent/KR20240067943A/ko unknown
- 2022-09-23 IL IL311564A patent/IL311564A/en unknown
- 2022-09-23 CA CA3233101A patent/CA3233101A1/en active Pending
- 2022-09-23 EP EP22873902.5A patent/EP4405484A2/en active Pending
-
2024
- 2024-03-27 CO CONC2024/0003968A patent/CO2024003968A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW202328449A (zh) | 2023-07-16 |
IL311564A (en) | 2024-05-01 |
CA3233101A1 (en) | 2023-03-30 |
WO2023049871A2 (en) | 2023-03-30 |
WO2023049871A3 (en) | 2023-04-27 |
AU2022348935A1 (en) | 2024-04-04 |
KR20240067943A (ko) | 2024-05-17 |
EP4405484A2 (en) | 2024-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2020002401A1 (es) | Composiciones de arni de 17 b-hidroxiesteroide deshidrogenasas tipo 13 (hsd17b13) y métodos de uso de las mismas. | |
CO2024003968A2 (es) | Composiciones de agentes de arni de proteína tau asociada a microtúbulos (mapt) y sus métodos de uso | |
CO2020015314A2 (es) | Composiciones de arni contra el angiotensinógeno (agt) y métodos para su uso | |
CL2020000991A1 (es) | Proteínas trispecíficas y métodos de uso. | |
DOP2019000132A (es) | COMPOSICIONES DE ARNi DE SERPINA1 Y SUS MÉTODOS DE USO DE LAS MISMAS. | |
CO2021009163A2 (es) | Composiciones de agente de arni de proteína precursora de amiloide (app) y método de uso de las mismas | |
BR112019005548A2 (pt) | tratamento da doença de huntington com aav | |
EA201792263A1 (ru) | КОМПОЗИЦИИ НА ОСНОВЕ iRNA ПРОТИВ АНГИОПОЭТИН-ПОДОБНОГО БЕЛКА 3 (ANGPTL3) И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
EA201790789A1 (ru) | Композиции и способы, предназначенные для ингибирования экспрессии гена hao1 (оксидазы 1 гидроксикислот (гликолат-оксидазы)) | |
BR112018014288A2 (pt) | métodos e composições para o tratamento de doença neurológica | |
BR112022001324A2 (pt) | Composto, composição farmacêutica e método para tratamento de uma doença mediada por p38 map quinase em um indivíduo necessitando do mesmo | |
CO2022016196A2 (es) | Composiciones de arni del factor b del complemento (cfb) y métodos de uso de las mismas | |
EA202191630A1 (ru) | ХИМИЧЕСКИ МОДИФИЦИРОВАННЫЕ КОНСТРУКЦИИ ДЛЯ RNAi И ПУТИ ИХ ПРИМЕНЕНИЯ | |
BR112019008810A2 (pt) | micrornas modificadas com 5-halouracila e seu uso no tratamento de câncer | |
BR112022019606A2 (pt) | Composições de agentes de irna para a proteína associada a microtúbulos tau (mapt) e métodos de uso das mesmas | |
CO2022009787A2 (es) | Agentes de arni del marco de lectura abierto 72 del cromosoma 9 humano (c9orf72), composiciones y métodos de uso de los mismos | |
CL2022001590A1 (es) | Composiciones de arni que contienen un dominio fosfolipasa tipo patatina 3 (pnpla3) y sus métodos | |
DOP2018000001A (es) | Moléculas de fusión | |
BR112021021686A2 (pt) | Moléculas inibidoras de ácido nucleico de fita dupla com fitas senso curtas | |
CO2022008105A2 (es) | Composiciones de arni que contienen un dominio fosfolipasa tipo patatina 3 (pnpla3) y sus métodos de uso | |
AR120341A1 (es) | COMPOSICIONES DE AGENTES DE ARNi CONTRA LA HUNTINGTINA (HTT) Y SUS MÉTODOS DE USO | |
BR112022021813A2 (pt) | Composições de agente de apolipoproteína e (apoe) irna e métodos de uso das mesmas | |
CL2022000539A1 (es) | Composiciones y métodos para inhibir la expresión del gen lect2 | |
AR121708A1 (es) | AGENTES Y COMPOSICIONES DE iRNA DE LA PROTEÍNA TAU ASOCIADA A MICROTÚBULOS (MAPT) Y SUS MÉTODOS DE USO | |
CO2023018579A2 (es) | Composiciones del agente de arni de la cinasa de repetición 2 rica en leucina (lrrk2 ) y métodos de uso de estas |